Tasly Pharmaceutical Group – World Class Benchmarking
Company: Tasly Pharmaceutical Group Company Limited
Bloomberg ticker: 600535 SH
Market cap: US$2,860m
Background: Tasly Pharmaceutical Group Company Limited manufactures drug products. The Company develops and sells traditional Chinese medicine, biological medicine, chemical medicine, and other related products.
World Class Benchmarking of Tasly Pharmaceutical Group
- Profitable Growth rank of 8 was up compared to the prior period’s 9th rank
- This is below average performance compared to 380 large Health Care companies worldwide
- Profitability rank of 7 was better than its Growth rank of 9
- Profitability rank of 7 was up compared to the prior period’s 9th rank
- This is below average performance compared to peers
- Growth rank of 9 was up compared to the prior period’s 10th rank
- This is poor performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.